Survivin polymorphisms and susceptibility to prostate cancer: A genetic association study and an in silico analysis

Survivin is a member of the apoptosis inhibitor protein family and its polymorphisms may lead to susceptibility to cancer. The aim of this study was to investigate the possible association of c.-31G>C (rs9904341), c.454G>A (rs2071214), c.*148T>C (rs2239680) and c.*571T>C (rs1042489) poly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EXCLI journal 2018-01, Vol.17, p.479-491
Hauptverfasser: Karimian, Mohammad, Aftabi, Younes, Mazoochi, Tahereh, Babaei, Faezeh, Khamechian, Tahereh, Boojari, Hossein, Nikzad, Hossein
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Survivin is a member of the apoptosis inhibitor protein family and its polymorphisms may lead to susceptibility to cancer. The aim of this study was to investigate the possible association of c.-31G>C (rs9904341), c.454G>A (rs2071214), c.*148T>C (rs2239680) and c.*571T>C (rs1042489) polymorphisms of gene with prostate cancer risk and provide some justification using analysis. The 157 men with prostate cancer and 145 healthy controls were included in a case-control study. The studied polymorphisms were genotyped using PCR-RFLP method. An approach was employed to show the possible effects of the polymorphisms on the survivin gene function. The study revealed that there are significant associations between c.-31CC genotype (OR= 2.29, 95 % CI= 1.20-4.37, = 0.012), c.-31C allele (OR= 1.62, 95 % CI= 1.17-2.26, = 0.004), c.454AG genotype (OR= 2.03, 95 % CI= 1.02-4.04, = 0.043), and c.*148C allele (OR= 1.49, 95 % CI= 1.04-2.15, = 0.031) with prostate cancer. Using stratified analysis, we found also significant effects of age distribution on the association of c.-31G>C with prostate cancer risk (OR= 2.10, 95 % CI= 1.08-4.10, = 0.030). Also as a preliminary study, it was shown that smoking status has significant effects on the association of c.-31G>C (OR= 1.94, 95 % CI= 1.08-3.49, = 0.027) and c.*148T>C (OR= 2.60, 95 % CI= 1.47-4.60, = 0.001) polymorphisms with prostate cancer risk. Finally, analysis revealed that c.-31G>C, which is located in a CpG island of the promoter may change transcriptional regulation of gene and c.454G>A and *148T>C could affect protein structure and possible miRNA interaction with 3'-UTR of transcript respectively. According to the results, c.-31G>C, c.454G>A, and c.*148T>C polymorphisms could be genetic risk factors for prostate cancer in an Iranian population. However, further studies with larger sample size and different ethnicities are required to obtain more comprehensive results.
ISSN:1611-2156
1611-2156
DOI:10.17179/excli2018-1234